Education
About Us
Working with TipRanks
Follow Us
Roquefort Investments PLC (GB:ROQ)
LSE:ROQ
ROQ Stock Chart & Stats
1.20p
-0.08p(-2.08%)
At close: 4:00 PM EST
1.20p
-0.08p(-2.08%)
Day’s Range― - ―
52-Week Range1.08p - 4.50p
Previous CloseN/A
Volume352.01K
Average Volume (3M)2.61M
Market Cap
£1.88M
Enterprise Value5.38M
Total Cash (Recent Filing)£182.92K
Total Debt (Recent Filing)£383.65K
Price to Earnings (P/E)―
Beta0.41
Next Earnings
May 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding163,726,290
10 Day Avg. Volume1,674,162
30 Day Avg. Volume2,613,232
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)1.07
Price to Sales (P/S)0.00
P/FCF Ratio-6.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Roquefort Investments PLC News
ROQ FAQ
What was Roquefort Investments PLC’s price range in the past 12 months?
Roquefort Investments PLC lowest stock price was 1.08p and its highest was 4.50p in the past 12 months.
What is Roquefort Investments PLC’s market cap?
Roquefort Investments PLC’s market cap is £1.88M.
When is Roquefort Investments PLC’s upcoming earnings report date?
Roquefort Investments PLC’s upcoming earnings report date is May 13, 2026 which is in 110 days.
How were Roquefort Investments PLC’s earnings last quarter?
Currently, no data Available
Is Roquefort Investments PLC overvalued?
According to Wall Street analysts Roquefort Investments PLC’s price is currently Overvalued.
Does Roquefort Investments PLC pay dividends?
Roquefort Investments PLC does not currently pay dividends.
What is Roquefort Investments PLC’s EPS estimate?
Roquefort Investments PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Roquefort Investments PLC have?
Roquefort Investments PLC has 163,726,290 shares outstanding.
What happened to Roquefort Investments PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Roquefort Investments PLC?
Currently, no hedge funds are holding shares in GB:ROQ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Roquefort Investments PLC
Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
Technical Analysis
Avacta Group plc
―
Cizzle Biotechnology Holdings PLC
―
PureTech Health
―
Sareum Holdings
―
Fusion Antibodies Plc
―
Ownership Overview
17.51% Insiders
―
Mutual Funds
― Other Institutional Investors
82.49% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---